Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the benzenesulfonamides class. It features a pyrrolidine ring substituted with a benzyloxymethyl group and an isobutyl (2-methylpropyl) side chain attached to the sulfonamide nitrogen. The compound has been structurally characterized and deposited in chemical databases such as DrugBank (DB07505), PubChem (CID 25113136), and ChemSpider. It has been studied as an experimental agent but does not have an established clinical use or approved indication. Notably, it appears in structural studies as a ligand for HIV protease complexes but lacks detailed published information on its mechanism of action or therapeutic application[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide.